# Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

> **NCT01781104** · PHASE2 · COMPLETED · sponsor: **Motus Therapeutics, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** RM-131
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01781104
- **Lead sponsor:** Motus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781104, "Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01781104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*